False aneurysm of a hepatic artery branch complicating intrahepatic islet transplantation

Transplant International : Official Journal of the European Society for Organ Transplantation
Nicholas OnacaMarlon F Levy


Islet transplantation, an innovative treatment strategy for type 1 diabetes mellitus, is a relatively safe procedure, with less morbidity than pancreas transplantation. Vascular injuries have not been reported to date. We report a percutaneous transhepatic intraportal islet transplant infusion that was followed by bleeding from a false aneurysm of an intrahepatic branch of the hepatic artery. The bleeding was controlled by selective embolization. Despite the complication and its treatment, the patient gained insulin independence, which was sustained for 285 days. She is currently on a small dose of insulin with good glycemic control.


Jun 1, 1997·Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine·G D SchweigerS J Rosenthal
Nov 20, 1997·Transplantation Proceedings·T KaratzasA G Tzakis
Oct 19, 1999·European Journal of Gastroenterology & Hepatology·A S AustinB Norton
Feb 24, 2001·The American Journal of Gastroenterology·A AhmedR C Cheung
Sep 22, 2001·AJR. American Journal of Roentgenology·C J RocheD C Morris
Nov 27, 2004·Journal of Gastroenterology·Tomotaka AkatsuMasaki Kitajima
Jun 29, 2005·Diabetes·Edmond A RyanA M James Shapiro
Jul 6, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Tatiana FroudRodolfo Alejandro
Dec 24, 2005·The Journal of Trauma·Rob SchusterKenneth Waxman
Aug 26, 2006·Cardiovascular and Interventional Radiology·Boris RadeleffGuenter W Kauffmann

❮ Previous
Next ❯


Jun 19, 2013·Transplantation·Nujen Colak BozkurtRodolfo Alejandro
Jul 17, 2012·Cell Transplantation·Morihito TakitaMarlon F Levy
Dec 13, 2018·Endocrine Reviews·Michael R Rickels, R Paul Robertson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.